There are two main goals to perform neoadjuvant systemic therapy for women with breast cancer. The first goal is to obtain a pathological complete response (PCA) and the second reason is because we want to perform a less aggressive surgery.In this OncologyPRO educational video of the "How to" series, Sofia Braga explains how to use neoadjuvant therapies in Breast cancer patients according to risk factors and tumour type.

Major Sponsors

AstraZeneca Bristol-Myers Squibb MSD Servier

Main Sponsors

Amgen Astellas Bayer Healthcare Boehringer Ingelheim Daiichi Sankyo ipsen Janssen Novartis Roche